-
1دورية أكاديمية
المؤلفون: Woodman, R. C.
المصدر: Journal of the Royal Statistical Society. Series C (Applied Statistics), 1969 Jan 01. 18(1), 31-40.
الوصول الحر: https://www.jstor.org/stable/2346437Test
-
2دورية أكاديمية
المؤلفون: Woodman, R. C.
المصدر: OR, 1967 Sep 01. 18(3), 267-280.
الوصول الحر: https://www.jstor.org/stable/3006977Test
-
3دورية أكاديمية
المؤلفون: Giles, F J, Mauro, M J, Hong, F, Ortmann, C-E, McNeill, C, Woodman, R C, Hochhaus, A, le Coutre, P D, Saglio, G
مصطلحات موضوعية: chronic myeloid leukemia, nilotinib, imatinib, ponatinib, tyrosine kinase inhibitor, peripheral arterial occlusive disease, diagnosed chronic-phase, risk-factors, matrix accumulation, follow-up, prevalence, mesylate, atherosclerosis, cardiotoxicity, management, sunitinib
العلاقة: Leukemia; Giles, F J; Mauro, M J; Hong, F; Ortmann, C-E; McNeill, C; Woodman, R C; Hochhaus, A; le Coutre, P D; Saglio, G (2013). Rates of peripheral arterial occlusive disease in patients with chronic myeloid leukemia in the chronic phase treated with imatinib, nilotinib, or non-tyrosine kinase therapy: a retrospective cohort analysis. Leukemia 27 (6), 1310-1315; 0887-6924,1476-5551; http://hdl.handle.net/10379/11638Test
-
4دورية أكاديمية
المؤلفون: Jabbour, E, le Coutre, P D, Cortes, J, Giles, F, Bhalla, K N, Pinilla-Ibarz, J, Larson, R A, Gattermann, N, Ottmann, O G, Hochhaus, A, Hughes, T P, Saglio, G, Radich, J P, Kim, D-W, Martinelli, G, Reynolds, J, Woodman, R C, Baccarani, M, Kantarjian, H M
مصطلحات موضوعية: chronic myeloid leukemia, nilotinib, multivariate analysis, predictive model, imatinib intolerance, imatinib resistance, chronic myelogenous leukemia, tyrosine kinase inhibitors, interferon-alpha, tumor response, failure, survival, mesylate, resistance, time
العلاقة: Leukemia; Jabbour, E; le Coutre, P D; Cortes, J; Giles, F; Bhalla, K N; Pinilla-Ibarz, J; Larson, R A; Gattermann, N; Ottmann, O G; Hochhaus, A; Hughes, T P; Saglio, G; Radich, J P; Kim, D-W; Martinelli, G; Reynolds, J; Woodman, R C; Baccarani, M; Kantarjian, H M (2012). Prediction of outcomes in patients with ph+ chronic myeloid leukemia in chronic phase treated with nilotinib after imatinib resistance/intolerance. Leukemia 27 (4), 907-913; 0887-6924,1476-5551; http://hdl.handle.net/10379/12051Test
-
5دورية أكاديمية
المؤلفون: Cortes, J. E., Hochhaus, A., le Coutre, P. D., Rosti, G., Pinilla-Ibarz, J., Jabbour, E., Gillis, K., Woodman, R. C., Blakesley, R. E., Giles, F. J., Kantarjian, H. M., Baccarani, M.
مصطلحات موضوعية: abl tyrosine kinase, chronic myelogenous leukemia, bcr-abl, inhibitor nilotinib, formerly amn107, pdgf receptors, resistance, growth
العلاقة: Blood; Cortes, J. E. Hochhaus, A.; le Coutre, P. D.; Rosti, G.; Pinilla-Ibarz, J.; Jabbour, E.; Gillis, K.; Woodman, R. C.; Blakesley, R. E.; Giles, F. J.; Kantarjian, H. M.; Baccarani, M. (2011). Minimal cross-intolerance with nilotinib in patients with chronic myeloid leukemia in chronic or accelerated phase who are intolerant to imatinib. Blood 117 (21), 5600-5606; 0006-4971,1528-0020; http://hdl.handle.net/10379/10921Test
-
6دورية أكاديمية
المؤلفون: Penninx, B. W. J. H., Pahor, M., Woodman, R. C., Guralnik, J. M.
المصدر: The Journals of Gerontology Series A: Biological Sciences and Medical Sciences ; volume 61, issue 5, page 474-479 ; ISSN 1079-5006 1758-535X
الإتاحة: https://doi.org/10.1093/gerona/61.5.474Test
http://academic.oup.com/biomedgerontology/article-pdf/61/5/474/1755571/474.pdfTest -
7دورية أكاديمية
المؤلفون: Chaves, P. H. M., Semba, R. D., Leng, S. X., Woodman, R. C., Ferrucci, L., Guralnik, J. M., Fried, L. P.
المصدر: The Journals of Gerontology Series A: Biological Sciences and Medical Sciences ; volume 60, issue 6, page 729-735 ; ISSN 1079-5006 1758-535X
مصطلحات موضوعية: Geriatrics and Gerontology, Aging
الإتاحة: https://doi.org/10.1093/gerona/60.6.729Test
http://academic.oup.com/biomedgerontology/article-pdf/60/6/729/9706850/729.pdfTest -
8دورية أكاديمية
المؤلفون: Woodman, R. C.
المصدر: OR, 1967 Jun 01. 18(2), 193-195.
الوصول الحر: https://www.jstor.org/stable/3007538Test
-
9دورية أكاديمية
المؤلفون: Agrawal, M, Hanfstein, B, Erben, P, Wolf, D, Ernst, T, Fabarius, A, Saussele, S, Purkayastha, D, Woodman, R C, Hofmann, W-K, Hehlmann, R, Hochhaus, A, Müller, M C
المصدر: Leukemia ; volume 28, issue 7, page 1478-1485 ; ISSN 0887-6924 1476-5551
مصطلحات موضوعية: Oncology, Cancer Research, Hematology
الإتاحة: https://doi.org/10.1038/leu.2014.6Test
https://www.nature.com/articles/leu20146.pdfTest
https://www.nature.com/articles/leu20146Test -
10دورية أكاديمية
المؤلفون: Ferrucci L., Guralnik J. M., Woodman R. C., Bandinelli S., Lauretani F., Corsi A. M., Chaves P. H. M., Ershler W. B., Longo D. L.
المساهمون: Ferrucci, L., Guralnik, J. M., Woodman, R. C., Bandinelli, S., Lauretani, F., Corsi, A. M., Chaves, P. H. M., Ershler, W. B., Longo, D. L.
مصطلحات موضوعية: Anemia, Cytokine, Erythropoietin, InCHIANTI, Inflammation
العلاقة: volume:118; issue:11; firstpage:1288; lastpage:1288.e19; journal:THE AMERICAN JOURNAL OF MEDICINE; http://hdl.handle.net/11381/2886434Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-27644439098